Immunotherapy applications of carbon nanotubes: From design to safe applications

Trends in Biotechnology

Volumn 32, Issue 4, 2014, Pages 198-209

  Fadel, Tarek R ^a   Fahmy, Tarek M ^a  

^a Yale University   (United States)

Author keywords

Cancer; Carbon nanotubes; Immune system; Immunotherapy; Toxicity; Vaccine

Indexed keywords

ASPECT RATIO; CELL MEMBRANES; CYTOLOGY; IMMUNE SYSTEM; SURFACE CHEMISTRY; TOXICITY; VACCINES;

CANCER; HIGH ASPECT RATIO; IMMUNE RESPONSE; IMMUNOTHERAPY; IMMUNOTOXICOLOGY; STRUCTURE AND MORPHOLOGY; THERAPEUTIC EFFICACY; VACCINE DEVELOPMENT;

CARBON NANOTUBES;

ANTIGEN; CARBON NANOTUBE; VACCINE;

ADAPTIVE IMMUNITY; CELL MEMBRANE; CLINICAL EFFECTIVENESS; COMPLEMENT SYSTEM; DRUG DELIVERY SYSTEM; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; IMMUNOTOXICITY; INFLAMMATION; INNATE IMMUNITY; MORPHOLOGY; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; SURFACE PROPERTY;

CANCER; CARBON NANOTUBES; IMMUNE SYSTEM; IMMUNOTHERAPY; TOXICITY; VACCINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOTECHNOLOGY; HUMANS; IMMUNOTHERAPY; MICE; NANOTUBES, CARBON; VACCINES;

EID: 84896547840     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2014.02.005     Document Type: Review

References (80)

1. Poland C.A., et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 2008, 3:423-428.
2. Kostarelos K., et al. Hype around nanotubes creates unrealistic hopes. Nature 2008, 453:280.
3. Iijima S. Helical microtubules of graphitic carbon. Nature 1991, 354:56-58.
4. Martin C.R., Kohli P. The emerging field of nanotube biotechnology. Nat. Rev. Drug Discov. 2003, 2:29-37.
5. Bianco A., et al. Opportunities and challenges of carbon-based nanomaterials for cancer therapy. Expert Opin. Drug Deliv. 2008, 5:331-342.
6. Tinkle S.S. Maximizing safe design of engineered nanomaterials: the NIH and NIEHS research perspective. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2010, 2:88-98.
7. Lopez C.F., et al. Understanding nature's design for a nanosyringe. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4431-4434.
8. Fadel T.R., et al. Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli. Nano Lett. 2008, 8:2070-2076.
9. Aldinucci A., et al. Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. Nano Lett. 2013, 13:6098-6105.
10. Dobrovolskaia M.A., McNeil S.E. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2007, 2:469-478.
11. Tasis D., et al. Chemistry of carbon nanotubes. Chem. Rev. 2006, 106:1105-1136.
12. Cai D., et al. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nat. Methods 2005, 2:449-454.
13. Shi X., et al. Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. Nat. Nanotechnol. 2011, 6:714-719.
14. Fadel T.R., et al. Adsorption of multimeric T cell antigens on carbon nanotubes: effect on protein structure and antigen-specific T cell stimulation. Small 2013, 9:666-672.
15. Ge C., et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:16968-16973.
16. Murphy K.P., et al. Janeway's Immunobiology 2008, Garland Science.
17. Waldmann T.A. Immunotherapy: past, present and future. Nat. Med. 2003, 9:269-277.
18. Swartz M.A., et al. Engineering approaches to immunotherapy. Sci. Transl. Med. 2012, 4:148rv9.
19. Demento S.L., et al. Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines. Trends Biotechnol. 2011, 29:294-306.
20. Pantarotto D., et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem. Biol. 2003, 10:961-966.
21. Meng J., et al. Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy. Small 2008, 4:1364-1370.
22. Niyogi S., et al. Chemistry of single-walled carbon nanotubes. Acc. Chem. Res. 2002, 35:1105-1113.
23. Banerjee S., et al. Covalent surface chemistry of single-walled carbon nanotubes. Adv. Mater. 2005, 17:17-29.
24. Lu F.S., et al. Advances in bioapplications of carbon nanotubes. Adv. Mater. 2009, 21:139-152.
25. Kostarelos K., et al. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 2009, 4:627-633.
26. Liu Z., et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2007, 2:47-52.
27. De La Zerda A., et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat. Nanotechnol. 2008, 3:557-562.
28. Chen Z., et al. Protein microarrays with carbon nanotubes as multicolor Raman labels. Nat. Biotechnol. 2008, 26:1285-1292.
29. Khabashesku V.N., et al. Fluorination of single-wall carbon nanotubes and subsequent derivatization reactions. Acc. Chem. Res. 2002, 35:1087-1095.
30. Stevens J.L., et al. Sidewall amino-functionalization of single-walled carbon nanotubes through fluorination and subsequent reactions with terminal diamines. Nano Lett. 2003, 3:331-336.
31. Tagmatarchis N., et al. Sidewall functionalization of single-walled carbon nanotubes through electrophilic addition. Chem. Commun. 2002, 2010-2011.
32. Georgakilas V., et al. Organic functionalization of carbon nanotubes. J. Am. Chem. Soc. 2002, 124:760-761.
33. Georgakilas V., et al. Amino acid functionalisation of water soluble carbon nanotubes. Chem. Commun. 2002, 3050-3051.
34. Hiura H., et al. Opening and purification of carbon nanotubes in high yields. Adv. Mater. 1995, 7:275-276.
35. Gratton S.E.A., et al. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:11613-11618.
36. Kostarelos K., et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol. 2007, 2:108-113.
37. Fan H.T., et al. Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in mice. Clin. Cancer Res. 2012, 18:5628-5638.
38. Bianco A., et al. Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties. J. Am. Chem. Soc. 2005, 127:58-59.
39. Restifo N.P., et al. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat. Rev. Immunol. 2012, 12:269-281.
40. Steenblock E.R., et al. Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy. Expert Opin. Biol. Ther. 2009, 9:451-464.
41. Fadel T.R., et al. Clustering of stimuli on single-walled carbon nanotube bundles enhances cellular activation. Langmuir 2010, 26:5645-5654.
42. Aillon K.L., et al. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Deliv. Rev. 2009, 61:457-466.
43. Rihova B. Immunocompatibility and biocompatibility of cell delivery systems. Adv. Drug Deliv. Rev. 2000, 42:65-80.
44. Rybak-Smith M.J., Sim R.B. Complement activation by carbon nanotubes. Adv. Drug Deliv. Rev. 2011, 63:1031-1041.
45. Dumortier H. When carbon nanotubes encounter the immune system: desirable and undesirable effects. Adv. Drug Deliv. Rev. 2013, 65:2120-2126.
46. Salvador-Morales C., et al. Complement activation and protein adsorption by carbon nanotubes. Mol. Immunol. 2006, 43:193-201.
47. Hamad I., et al. Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. Mol. Immunol. 2008, 45:3797-3803.
48. Dumortier H., et al. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells (vol 6, pg 1522, 2006). Nano Lett. 2006, 6:1522-1528.
49. Porter A.E., et al. Uptake of noncytotoxic acid-treated single-walled carbon nanotubes into the cytoplasm of human macrophage cells. ACS Nano 2009, 3:1485-1492.
50. Kagan V.E., et al. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: Role of iron. Toxicol. Lett. 2006, 165:88-100.
51. Delogu L.G., et al. Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine (Lond.) 2012, 7:231-243.
52. Brown D.M., et al. An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis. Carbon 2007, 45:1743-1756.
53. Yang S.T., et al. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. Toxicol. Lett. 2008, 181:182-189.
54. Konduru N.V., et al. Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo. PLoS ONE 2009, 4:e4398.
55. Katwa P., et al. A carbon nanotube toxicity paradigm driven by mast cells and the IL-33ST2 axis. Small 2012, 8:2904-2912.
56. Palomaki J., et al. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 2011, 5:6861-6870.
57. Meunier E., et al. Double-walled carbon nanotubes trigger IL-1 β release in human monocytes through Nlrp3 inflammasome activation. Nanomedicine 2012, 8:987-995.
58. Franchi L., et al. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 2009, 10:241-247.
59. Sun B., et al. NLRP3 inflammasome activation induced by engineered nanomaterials. Small 2012, 9:1595-1607.
60. Bottini M., et al. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol. Lett. 2006, 160:121-126.
61. Tkach A.V., et al. Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano 2011, 5:5755-5762.
62. Alam A., et al. Interactions of polydispersed single-walled carbon nanotubes with T cells resulting in downregulation of allogeneic CTL responses in vitro and in vivo. Nanotoxicology 2013, 7:1351-1360.
63. Mitchell L.A., et al. Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat. Nanotechnol. 2009, 4:451-456.
64. Kagan V.E., et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat. Nanotechnol. 2010, 5:354-359.
65. Porter A.E., et al. Direct imaging of single-walled carbon nanotubes in cells. Nat. Nanotechnol. 2007, 2:713-717.
66. Wang J., et al. Multi-walled carbon nanotubes do not impair immune functions of dendritic cells. Carbon 2009, 47:1752-1760.
67. Nel A.E., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8:543-557.
68. Mu Q., et al. Endosomal leakage and nuclear translocation of multiwalled carbon nanotubes: developing a model for cell uptake. Nano Lett. 2009, 9:4370-4375.
69. Porter A., et al. Effects of functionalization on the targeting site of carbon nanotubes inside cells. J. Phys.: Conf. Ser. 2010, 241. 10.1088/1742-6596/241/1/012018.
70. Zhou F., et al. New insights of transmembranal mechanism and subcellular localization of noncovalently modified single-walled carbon nanotubes. Nano Lett. 2010, 10:1677-1681.
71. Holt B.D., et al. Quantification of uptake and localization of bovine serum albumin-stabilized single-wall carbon nanotubes in different human cell types. Small 2011, 7:2348-2355.
72. Guermonprez P., et al. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002, 20:621-667.
73. Eisenbarth S.C., et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126.
74. Villa C.H., et al. Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens. ACS Nano 2011, 5:5300-5311.
75. Zhao D., et al. Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity. Clin. Cancer Res. 2011, 17:771-782.
76. Sacchetti C., et al. In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes. Bioconjug. Chem. 2013, 24:852-858.
77. Zhou F., et al. Antitumor immunologically modified carbon nanotubes for photothermal therapy. Biomaterials 2012, 33:3235-3242.
78. Kam N.W., et al. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J. Am. Chem. Soc. 2005, 127:12492-12493.
79. VanHandel M., et al. Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model. J. Neuroimmunol. 2009, 208:3-9.
80. Zhang J., et al. Effect of single-walled carbon nanotubes on primary immune cells in vitro. Front. Mater. Sci. China 2008, 2:228-232.